Pharmaceuticals - Algeria

  • Algeria
  • The Pharmaceuticals market in Algeria is expected to achieve a revenue of US$1,006.00m in 2024.
  • Among the various markets, the largest one is Oncology Drugs, which is projected to have a market volume of US$174.30m in 2024.
  • Over the period from 2024 to 2029, the revenue is anticipated to demonstrate an annual growth rate (CAGR 2024-2029) of 4.20%, resulting in a market volume of US$1,236.00m by 2029.
  • In terms of global comparison, United States is expected to generate the highest revenue, amounting to US$630.30bn in 2024.
  • Algeria's pharmaceutical market is experiencing a surge in demand for generic drugs due to government efforts to reduce healthcare costs.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmaceuticals market in Algeria has been experiencing significant growth in recent years.

Customer preferences:
Algerian consumers have been showing a growing preference for locally produced pharmaceuticals, as they tend to be more affordable than imported brands. This trend has been driven by the government's efforts to increase domestic production and reduce reliance on imports. Additionally, there is a growing demand for generic drugs, which are seen as more cost-effective alternatives to branded medications.

Trends in the market:
One of the key trends in the Algerian Pharmaceuticals market is the increasing focus on research and development. Local companies are investing heavily in R&D to develop new drugs and improve existing ones, in order to meet the growing demand for high-quality pharmaceuticals. Another trend is the increasing adoption of digital technologies, such as telemedicine and e-prescriptions, which are helping to improve access to healthcare services in remote areas.

Local special circumstances:
Algeria has a large and growing population, which is driving demand for healthcare services and pharmaceuticals. However, the country's healthcare infrastructure is still relatively underdeveloped, particularly in rural areas. This has created opportunities for companies to invest in the development of healthcare facilities and services, as well as the production and distribution of pharmaceuticals.

Underlying macroeconomic factors:
Algeria's economy has been growing steadily in recent years, driven by strong performance in the oil and gas sector. This has led to increased government spending on healthcare and social services, which has helped to support the growth of the Pharmaceuticals market. Additionally, the government has implemented a number of policies aimed at promoting domestic production and reducing reliance on imports, which has created opportunities for local companies to expand their operations.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)